Global Antisense Oligonucleotides (ASO) Therapy Supply, Demand and Key Producers, 2024-2030

Page: 85

Published Date: 14 May 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases
The global Antisense Oligonucleotides (ASO) Therapy market size is expected to reach $ 10580 million by 2030, rising at a market growth of 16.9% CAGR during the forecast period (2024-2030).

This report studies the global Antisense Oligonucleotides (ASO) Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Antisense Oligonucleotides (ASO) Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antisense Oligonucleotides (ASO) Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Antisense Oligonucleotides (ASO) Therapy total market, 2019-2030, (USD Million)
Global Antisense Oligonucleotides (ASO) Therapy total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Antisense Oligonucleotides (ASO) Therapy total market, key domestic companies, and share, (USD Million)
Global Antisense Oligonucleotides (ASO) Therapy revenue by player, revenue and market share 2019-2024, (USD Million)
Global Antisense Oligonucleotides (ASO) Therapy total market by Type, CAGR, 2019-2030, (USD Million)
Global Antisense Oligonucleotides (ASO) Therapy total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Antisense Oligonucleotides (ASO) Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ionis Pharmaceuticals, Biogen, Sobi, Nippon Shinyaku, Jazz Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Antisense Oligonucleotides (ASO) Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Antisense Oligonucleotides (ASO) Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Antisense Oligonucleotides (ASO) Therapy Market, Segmentation by Type
    Intrathecal Injection
    Intravenous Injections
    Other

Global Antisense Oligonucleotides (ASO) Therapy Market, Segmentation by Application:
    Neuromuscular Diseases
    hATTR
    Other

Companies Profiled:
    Ionis Pharmaceuticals
    Biogen
    Sobi
    Nippon Shinyaku
    Jazz Pharmaceuticals

Key Questions Answered
1. How big is the global Antisense Oligonucleotides (ASO) Therapy market?
2. What is the demand of the global Antisense Oligonucleotides (ASO) Therapy market?
3. What is the year over year growth of the global Antisense Oligonucleotides (ASO) Therapy market?
4. What is the total value of the global Antisense Oligonucleotides (ASO) Therapy market?
5. Who are the Major Players in the global Antisense Oligonucleotides (ASO) Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Antisense Oligonucleotides (ASO) Therapy Introduction
    1.2 World Antisense Oligonucleotides (ASO) Therapy Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Antisense Oligonucleotides (ASO) Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Antisense Oligonucleotides (ASO) Therapy Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030)
        1.3.3 China Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030)
        1.3.4 Europe Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030)
        1.3.5 Japan Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030)
        1.3.6 South Korea Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030)
        1.3.7 ASEAN Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030)
        1.3.8 India Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Antisense Oligonucleotides (ASO) Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030)
    2.2 World Antisense Oligonucleotides (ASO) Therapy Consumption Value by Region
        2.2.1 World Antisense Oligonucleotides (ASO) Therapy Consumption Value by Region (2019-2024)
        2.2.2 World Antisense Oligonucleotides (ASO) Therapy Consumption Value Forecast by Region (2025-2030)
    2.3 United States Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030)
    2.4 China Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030)
    2.5 Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030)
    2.6 Japan Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030)
    2.7 South Korea Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030)
    2.8 ASEAN Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030)
    2.9 India Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030)

3 World Antisense Oligonucleotides (ASO) Therapy Companies Competitive Analysis
    3.1 World Antisense Oligonucleotides (ASO) Therapy Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Antisense Oligonucleotides (ASO) Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Antisense Oligonucleotides (ASO) Therapy in 2023
        3.2.3 Global Concentration Ratios (CR8) for Antisense Oligonucleotides (ASO) Therapy in 2023
    3.3 Antisense Oligonucleotides (ASO) Therapy Company Evaluation Quadrant
    3.4 Antisense Oligonucleotides (ASO) Therapy Market: Overall Company Footprint Analysis
        3.4.1 Antisense Oligonucleotides (ASO) Therapy Market: Region Footprint
        3.4.2 Antisense Oligonucleotides (ASO) Therapy Market: Company Product Type Footprint
        3.4.3 Antisense Oligonucleotides (ASO) Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Antisense Oligonucleotides (ASO) Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Antisense Oligonucleotides (ASO) Therapy Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Antisense Oligonucleotides (ASO) Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Antisense Oligonucleotides (ASO) Therapy Consumption Value Comparison
        4.2.1 United States VS China: Antisense Oligonucleotides (ASO) Therapy Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Antisense Oligonucleotides (ASO) Therapy Companies and Market Share, 2019-2024
        4.3.1 United States Based Antisense Oligonucleotides (ASO) Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Antisense Oligonucleotides (ASO) Therapy Revenue, (2019-2024)
    4.4 China Based Companies Antisense Oligonucleotides (ASO) Therapy Revenue and Market Share, 2019-2024
        4.4.1 China Based Antisense Oligonucleotides (ASO) Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Antisense Oligonucleotides (ASO) Therapy Revenue, (2019-2024)
    4.5 Rest of World Based Antisense Oligonucleotides (ASO) Therapy Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Antisense Oligonucleotides (ASO) Therapy Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Antisense Oligonucleotides (ASO) Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Intrathecal Injection
        5.2.2 Intravenous Injections
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2019-2024)
        5.3.2 World Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2025-2030)
        5.3.3 World Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Antisense Oligonucleotides (ASO) Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Neuromuscular Diseases
        6.2.2 hATTR
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024)
        6.3.2 World Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2025-2030)
        6.3.3 World Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Ionis Pharmaceuticals
        7.1.1 Ionis Pharmaceuticals Details
        7.1.2 Ionis Pharmaceuticals Major Business
        7.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product and Services
        7.1.4 Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Ionis Pharmaceuticals Recent Developments/Updates
        7.1.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
    7.2 Biogen
        7.2.1 Biogen Details
        7.2.2 Biogen Major Business
        7.2.3 Biogen Antisense Oligonucleotides (ASO) Therapy Product and Services
        7.2.4 Biogen Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Biogen Recent Developments/Updates
        7.2.6 Biogen Competitive Strengths & Weaknesses
    7.3 Sobi
        7.3.1 Sobi Details
        7.3.2 Sobi Major Business
        7.3.3 Sobi Antisense Oligonucleotides (ASO) Therapy Product and Services
        7.3.4 Sobi Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Sobi Recent Developments/Updates
        7.3.6 Sobi Competitive Strengths & Weaknesses
    7.4 Nippon Shinyaku
        7.4.1 Nippon Shinyaku Details
        7.4.2 Nippon Shinyaku Major Business
        7.4.3 Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Product and Services
        7.4.4 Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Nippon Shinyaku Recent Developments/Updates
        7.4.6 Nippon Shinyaku Competitive Strengths & Weaknesses
    7.5 Jazz Pharmaceuticals
        7.5.1 Jazz Pharmaceuticals Details
        7.5.2 Jazz Pharmaceuticals Major Business
        7.5.3 Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product and Services
        7.5.4 Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Jazz Pharmaceuticals Recent Developments/Updates
        7.5.6 Jazz Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Antisense Oligonucleotides (ASO) Therapy Industry Chain
    8.2 Antisense Oligonucleotides (ASO) Therapy Upstream Analysis
    8.3 Antisense Oligonucleotides (ASO) Therapy Midstream Analysis
    8.4 Antisense Oligonucleotides (ASO) Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Antisense Oligonucleotides (ASO) Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Antisense Oligonucleotides (ASO) Therapy Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Antisense Oligonucleotides (ASO) Therapy Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Antisense Oligonucleotides (ASO) Therapy Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Antisense Oligonucleotides (ASO) Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Antisense Oligonucleotides (ASO) Therapy Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Antisense Oligonucleotides (ASO) Therapy Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Antisense Oligonucleotides (ASO) Therapy Players in 2023
 Table 12. World Antisense Oligonucleotides (ASO) Therapy Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Antisense Oligonucleotides (ASO) Therapy Company Evaluation Quadrant
 Table 14. Head Office of Key Antisense Oligonucleotides (ASO) Therapy Players
 Table 15. Antisense Oligonucleotides (ASO) Therapy Market: Company Product Type Footprint
 Table 16. Antisense Oligonucleotides (ASO) Therapy Market: Company Product Application Footprint
 Table 17. Antisense Oligonucleotides (ASO) Therapy Mergers & Acquisitions Activity
 Table 18. United States VS China Antisense Oligonucleotides (ASO) Therapy Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Antisense Oligonucleotides (ASO) Therapy Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Antisense Oligonucleotides (ASO) Therapy Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Antisense Oligonucleotides (ASO) Therapy Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Antisense Oligonucleotides (ASO) Therapy Revenue Market Share (2019-2024)
 Table 23. China Based Antisense Oligonucleotides (ASO) Therapy Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Antisense Oligonucleotides (ASO) Therapy Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Antisense Oligonucleotides (ASO) Therapy Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Antisense Oligonucleotides (ASO) Therapy Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Antisense Oligonucleotides (ASO) Therapy Revenue Market Share (2019-2024)
 Table 29. World Antisense Oligonucleotides (ASO) Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Antisense Oligonucleotides (ASO) Therapy Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Antisense Oligonucleotides (ASO) Therapy Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Antisense Oligonucleotides (ASO) Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2025-2030) & (USD Million)
 Table 35. Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 36. Ionis Pharmaceuticals Major Business
 Table 37. Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product and Services
 Table 38. Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Ionis Pharmaceuticals Recent Developments/Updates
 Table 40. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
 Table 41. Biogen Basic Information, Manufacturing Base and Competitors
 Table 42. Biogen Major Business
 Table 43. Biogen Antisense Oligonucleotides (ASO) Therapy Product and Services
 Table 44. Biogen Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Biogen Recent Developments/Updates
 Table 46. Biogen Competitive Strengths & Weaknesses
 Table 47. Sobi Basic Information, Manufacturing Base and Competitors
 Table 48. Sobi Major Business
 Table 49. Sobi Antisense Oligonucleotides (ASO) Therapy Product and Services
 Table 50. Sobi Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Sobi Recent Developments/Updates
 Table 52. Sobi Competitive Strengths & Weaknesses
 Table 53. Nippon Shinyaku Basic Information, Manufacturing Base and Competitors
 Table 54. Nippon Shinyaku Major Business
 Table 55. Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Product and Services
 Table 56. Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Nippon Shinyaku Recent Developments/Updates
 Table 58. Nippon Shinyaku Competitive Strengths & Weaknesses
 Table 59. Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 60. Jazz Pharmaceuticals Major Business
 Table 61. Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product and Services
 Table 62. Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Jazz Pharmaceuticals Recent Developments/Updates
 Table 64. Jazz Pharmaceuticals Competitive Strengths & Weaknesses
 Table 65. Global Key Players of Antisense Oligonucleotides (ASO) Therapy Upstream (Raw Materials)
 Table 66. Global Antisense Oligonucleotides (ASO) Therapy Typical Customers


List of Figures
 Figure 1. Antisense Oligonucleotides (ASO) Therapy Picture
 Figure 2. World Antisense Oligonucleotides (ASO) Therapy Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Antisense Oligonucleotides (ASO) Therapy Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Antisense Oligonucleotides (ASO) Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Antisense Oligonucleotides (ASO) Therapy Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Antisense Oligonucleotides (ASO) Therapy Revenue (2019-2030) & (USD Million)
 Figure 13. Antisense Oligonucleotides (ASO) Therapy Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Antisense Oligonucleotides (ASO) Therapy by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Antisense Oligonucleotides (ASO) Therapy Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Antisense Oligonucleotides (ASO) Therapy Markets in 2023
 Figure 27. United States VS China: Antisense Oligonucleotides (ASO) Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Antisense Oligonucleotides (ASO) Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type in 2023
 Figure 31. Intrathecal Injection
 Figure 32. Intravenous Injections
 Figure 33. Other
 Figure 34. World Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Type (2019-2030)
 Figure 35. World Antisense Oligonucleotides (ASO) Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 36. World Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application in 2023
 Figure 37. Neuromuscular Diseases
 Figure 38. hATTR
 Figure 39. Other
 Figure 40. World Antisense Oligonucleotides (ASO) Therapy Market Size Market Share by Application (2019-2030)
 Figure 41. Antisense Oligonucleotides (ASO) Therapy Industrial Chain
 Figure 42. Methodology
 Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Ionis Pharmaceuticals
Biogen
Sobi
Nippon Shinyaku
Jazz Pharmaceuticals

Related Reports

Global Antisense Oligonucleotides (ASO) Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Antisense Oligonucleotides (ASO) Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 14 May 2024

date Pharma & Healthcare

Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases

Product Tags

Antisense Oligonucleotides (ASO) Therapy

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>